Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Sunovion To Purchase Elevation And Phase II Drug/Device Combo For COPD

Aug 31 2012

Related Content

With $30 Million Series B In Hand, Elevation Prepares To Take Inhalable COPD Drug Up To Phase III

Jan 04 2012

Related Companies

Elevation Pharmaceuticals, Inc.

Sumitomo Pharma Co., Ltd.

PARI GmbH

Novartis AG

Sumitomo Pharma Co., Ltd.

Additional Topics

United States Japan Asia Pacific Deals Business Strategies BioPharmaceutical Combination Products

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window